Aduhelm is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Biogen Inc.. The primary component is Aducanumab.
| Product ID | 64406-102_389fccbc-5f19-4f85-bd4c-e6160a45b242 |
| NDC | 64406-102 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Aduhelm |
| Generic Name | Aducanumab |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-06-07 |
| Marketing Category | BLA / |
| Application Number | BLA761178 |
| Labeler Name | Biogen Inc. |
| Substance Name | ADUCANUMAB |
| Active Ingredient Strength | 100 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-06-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 64406-101 | Aduhelm | Aducanumab |
| 64406-102 | Aduhelm | Aducanumab |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ADUHELM 90709506 not registered Live/Pending |
Biogen MA Inc. 2021-05-13 |
![]() ADUHELM 88841987 not registered Live/Pending |
Biogen MA Inc. 2020-03-20 |
![]() ADUHELM 87840337 not registered Live/Pending |
Biogen MA, Inc. 2018-03-19 |